FDA/NIH Human Safety Trial Approval for OUD
The clearing of the Investigational New Drug (IND) application by the FDA on June 1, 2026 marks the first federally sanctioned, randomized […]
The clearing of the Investigational New Drug (IND) application by the FDA on June 1, 2026 marks the first federally sanctioned, randomized […]
The Physiologically Based Pharmacokinetic (PBPK) model developed by Chiang et al. in early 2026 is a massive leap forward for
Research in early 2026 has shifted from broad observations to a specific pharmacological breakdown of kratom’s individual alkaloids. The scientific
The NIDA (National Institute on Drug Abuse) and the NIH HEAL (Helping to End Addiction Long-term) Initiative represent the most significant federal investment in
What’s New in Thailand (2024–2025) on Kratom What This Means
📌 1. Overview Red Maeng Da is one of the most potent and widely recognized red vein kratom strains. Known for
📌 1. Overview White Maeng Da is one of the most popular and potent white vein kratom strains, originally cultivated in Thailand and
When people first start exploring kratom, one name almost always comes up: Green Maeng Da. It has earned its place as
What We Know: Key Details of the SAD Trial What It Suggests (Implications) What We Don’t Know (Remaining Questions &
Who Conducted It? This research was led by scientists funded by the National Institute on Drug Abuse (NIDA) in collaboration with academic